Christopher Davis’s BIOMED REALTY TRUST INC BMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-193,950
Closed -$4.59M 200
2015
Q4
$4.59M Sell
193,950
-272,300
-58% -$6.33M 0.02% 151
2015
Q3
$9.32M Buy
+466,250
New +$9.32M 0.04% 122
2015
Q1
Sell
-779,101
Closed -$16.8M 205
2014
Q4
$16.8M Sell
779,101
-36,706
-4% -$782K 0.05% 87
2014
Q3
$16.5M Buy
815,807
+86,477
+12% +$1.88M 0.05% 90
2014
Q2
$15.9M Buy
729,330
+1,079
+0.1% +$22.9K 0.05% 96
2014
Q1
$14.9M Buy
728,251
+65,072
+10% +$1.28M 0.04% 97
2013
Q4
$12M Sell
663,179
-12,091
-2% -$229K 0.03% 107
2013
Q3
$12.6M Buy
675,270
+83,646
+14% +$1.64M 0.03% 98
2013
Q2
$12M Buy
+591,624
New +$12.8M 0.03% 124

Other funds holding BMR

Christopher Davis's BMR Position: Q1 2016 in Review

Christopher Davis sold out of BIOMED REALTY TRUST INC (BMR) in Q1 2016, closing a stake of 193,950 shares — an estimated $4.59M sold.

Christopher Davis first reported a position in BMR in Q2 2013 and held it in 9 quarters. The position peaked at $16.8M in Q4 2014. 4 funds tracked by Wall St. Rank hold BMR as of Q1 2016.

  • Christopher Davis reported no remaining BIOMED REALTY TRUST INC position as of Q1 2016 after selling out during the quarter.
  • Christopher Davis sold 193,950 BIOMED REALTY TRUST INC shares in Q1 2016, an estimated $4.59M.
  • Christopher Davis first reported a position in BIOMED REALTY TRUST INC in Q2 2013 and held it in 9 quarters.
  • Christopher Davis's BIOMED REALTY TRUST INC position peaked at $16.8M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held BIOMED REALTY TRUST INC as of Q1 2016.

Based on Davis Selected Advisers's 13F filing for Q1 2016, filed 13 May 2016.